Network, N. C. C. (2012). Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board. Business Wire (English).
Chicago Style (17th ed.) CitationNetwork, National Comprehensive Cancer. "Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board." Business Wire (English) 2012.
MLA (9th ed.) CitationNetwork, National Comprehensive Cancer. "Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board." Business Wire (English), 2012.
Warning: These citations may not always be 100% accurate.